These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12913198)

  • 1. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.
    Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW
    Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcortical ischemic vascular dementia: assessment with quantitative MR imaging and 1H MR spectroscopy.
    Capizzano AA; Schuff N; Amend DL; Tanabe JL; Norman D; Maudsley AA; Jagust W; Chui HC; Fein G; Segal MR; Weiner MW
    AJNR Am J Neuroradiol; 2000 Apr; 21(4):621-30. PubMed ID: 10782769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.
    Du AT; Schuff N; Laakso MP; Zhu XP; Jagust WJ; Yaffe K; Kramer JH; Miller BL; Reed BR; Norman D; Chui HC; Weiner MW
    Neurology; 2002 Jun; 58(11):1635-41. PubMed ID: 12058091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients.
    Chao LL; Schuff N; Kramer JH; Du AT; Capizzano AA; O'Neill J; Wolkowitz OM; Jagust WJ; Chui HC; Miller BL; Yaffe K; Weiner MW
    Neurology; 2005 Jan; 64(2):282-9. PubMed ID: 15668426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD; Rai GS
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.
    Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Kramer J; Jagust W; Miller B; Wolkowitz OM; Yaffe K; Weiner MW
    Neurology; 2002 Mar; 58(6):928-35. PubMed ID: 11914410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
    Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
    Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.
    MacKay S; Ezekiel F; Di Sclafani V; Meyerhoff DJ; Gerson J; Norman D; Fein G; Weiner MW
    Radiology; 1996 Feb; 198(2):537-45. PubMed ID: 8596863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease.
    Fein G; Di Sclafani V; Tanabe J; Cardenas V; Weiner MW; Jagust WJ; Reed BR; Norman D; Schuff N; Kusdra L; Greenfield T; Chui H
    Neurology; 2000 Dec; 55(11):1626-35. PubMed ID: 11113215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.
    Shiino A; Watanabe T; Shirakashi Y; Kotani E; Yoshimura M; Morikawa S; Inubushi T; Akiguchi I
    J Cereb Blood Flow Metab; 2012 May; 32(5):805-15. PubMed ID: 22314267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of diffusion tensor imaging in the differential diagnosis of subcortical ischemic vascular dementia and Alzheimer's disease in patients with only mild white matter alterations on T2-weighted images.
    Fu JL; Zhang T; Chang C; Zhang YZ; Li WB
    Acta Radiol; 2012 Apr; 53(3):312-7. PubMed ID: 22416261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
    Jones RS; Waldman AD
    Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcortical gray matter N-acetylaspartate reduction in two cases of vascular dementia.
    Ben Salem D; Walker PM; Osseby GV; Krausé D; Giroud M; Brunotte F
    Clin Imaging; 2003; 27(1):14-7. PubMed ID: 12504314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia.
    Kattapong VJ; Brooks WM; Wesley MH; Kodituwakku PW; Rosenberg GA
    Arch Neurol; 1996 Jul; 53(7):678-80. PubMed ID: 8929176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease.
    Mungas D; Jagust WJ; Reed BR; Kramer JH; Weiner MW; Schuff N; Norman D; Mack WJ; Willis L; Chui HC
    Neurology; 2001 Dec; 57(12):2229-35. PubMed ID: 11756602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1H MR spectroscopy in common dementias.
    Kantarci K; Petersen RC; Boeve BF; Knopman DS; Tang-Wai DF; O'Brien PC; Weigand SD; Edland SD; Smith GE; Ivnik RJ; Ferman TJ; Tangalos EG; Jack CR
    Neurology; 2004 Oct; 63(8):1393-8. PubMed ID: 15505154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study.
    Schuff N; Amend D; Ezekiel F; Steinman SK; Tanabe J; Norman D; Jagust W; Kramer JH; Mastrianni JA; Fein G; Weiner MW
    Neurology; 1997 Dec; 49(6):1513-21. PubMed ID: 9409338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuropsychological profile and its correlation with neuroimaging markers in patients with subcortical ischaemic vascular dementia.
    Tian R; Zhang Y; Liu F; Xue X; Zhang Y; Tian Z; Fang T; Fan R; Li Y; Zhang N
    Int J Geriatr Psychiatry; 2023 Mar; 38(3):e5900. PubMed ID: 36862560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.